Spyre Therapeutics (NASDAQ:SYRE) CEO Cameron Turtle Sells 15,000 Shares

Spyre Therapeutics, Inc. (NASDAQ: SYRE - Get Free Report) CEO Cameron Turtle sold 15,000 shares of the firm's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $49.33, for a total value of $739,950.00. Following the sale, the chief executive officer directly owned 627,540 shares in the company,